Michael Robert A.

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 5% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Michael Robert A.'s trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
123.14
Quantity 19,465 -25.6%
Value US$4,373,087
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
480.38
Quantity 29,892 +28.8%
Value US$1,276,097
US Abbvie Inc (ABBV)
Transaction date
Proposed sale
Price
192.40
Quantity 21,118
Value US$4,703,656
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
149.06
Quantity 4,236 -10.1%
Value US$631,432
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
148.49
Quantity 26,937 -39.0%
Value US$3,999,878
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
147.41
Quantity 11,932 -14.7%
Value US$1,758,937
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
119.43
Quantity 4,294 -38.4%
Value US$512,853
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
120.33
Quantity 592 -4.2%
Value US$71,235
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
120.29
Quantity 400 -2.7%
Value US$48,116
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
88.00
Quantity 6,699 -40.1%
Value US$589,512
US Abbvie Inc (ABBV)
Transaction date
Sale
Price
65.29
Quantity 5,132 -23.5%
Value US$335,068
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-01 2024-02-29
US Abbvie Inc (ABBV)
S Sale
19,465 -25.6%
123.14
US$4,373,087 		19,465 -25.6% 123.14 US$4,373,087
2024-03-01 2024-02-29
US Abbvie Inc (ABBV)
S Sale
29,892 +28.8%
480.38
US$1,276,097 		29,892 +28.8% 480.38 US$1,276,097
2024-02-29 2024-02-29
US Abbvie Inc (ABBV)
PrS Proposed sale
21,118
192.40
US$4,703,656 		21,118 192.40 US$4,703,656
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
4,236 -10.1%
149.06
US$631,432 		4,236 -10.1% 149.06 US$631,432
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
26,937 -39.0%
148.49
US$3,999,878 		26,937 -39.0% 148.49 US$3,999,878
2022-03-01 2022-03-01
US Abbvie Inc (ABBV)
S Sale
11,932 -14.7%
147.41
US$1,758,937 		11,932 -14.7% 147.41 US$1,758,937
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
4,294 -38.4%
119.43
US$512,853 		4,294 -38.4% 119.43 US$512,853
2018-02-20 2018-02-20
US Abbvie Inc (ABBV)
S Sale
592 -4.2%
120.33
US$71,235 		592 -4.2% 120.33 US$71,235
2018-02-20 2018-02-20
US Abbvie Inc (ABBV)
S Sale
400 -2.7%
120.29
US$48,116 		400 -2.7% 120.29 US$48,116
2017-09-29 2017-09-28
US Abbvie Inc (ABBV)
S Sale
6,699 -40.1%
88.00
US$589,512 		6,699 -40.1% 88.00 US$589,512
2017-03-10 2017-03-10
US Abbvie Inc (ABBV)
S Sale
5,132 -23.5%
65.29
US$335,068 		5,132 -23.5% 65.29 US$335,068